l-Cystine Diamides as l-Cystine Crystallization Inhibitors for Cystinuria

J Med Chem. 2016 Aug 11;59(15):7293-8. doi: 10.1021/acs.jmedchem.6b00647. Epub 2016 Jul 26.

Abstract

l-Cystine bismorpholide (1a) and l-cystine bis(N'-methylpiperazide) (1b) were seven and twenty-four times more effective than l-cystine dimethyl ester (CDME) in increasing the metastable supersaturation range of l-cystine, respectively, effectively inhibiting l-cystine crystallization. This behavior can be attributed to inhibition of crystal growth at microscopic length scale, as revealed by atomic force microscopy. Both 1a and 1b are more stable than CDME, and 1b was effective in vivo in a knockout mouse model of cystinuria.

MeSH terms

  • Administration, Oral
  • Amino Acid Transport Systems, Basic / deficiency
  • Amino Acid Transport Systems, Neutral / deficiency
  • Animals
  • Cystine / administration & dosage
  • Cystine / chemistry
  • Cystine / therapeutic use*
  • Cystinuria / drug therapy*
  • Cystinuria / genetics
  • Diamide / administration & dosage
  • Diamide / chemistry
  • Diamide / therapeutic use*
  • Disease Models, Animal
  • Male
  • Mice
  • Mice, Knockout
  • Models, Molecular
  • Molecular Structure

Substances

  • Amino Acid Transport Systems, Basic
  • Amino Acid Transport Systems, Neutral
  • Slc3a1 protein, mouse
  • Diamide
  • Cystine